Showing results 1 to 20 of 67
next >
| Issue Date | Title | Author(s) |
| Jan-2022 | Accurate Single-Molecule Kinetic Isotope Effects | Guo, Yilin; Yang, Chen; Li, Huiping; Zhang, Lei; Zhou, Shuyao; Zhu, Xin; Fu, Huanyan; Li, Zhizhou; Liu, Zhirong; Jia, Chuancheng; Liu, Zitong; Zhu, Wenguang; Mo, Fanyang; Zhang, Deqing; Guo, Xuefeng |
| Aug-2021 | Activity of preclinical and phase I clinical trial of a novel androgen receptor antagonist GT0918 in metastatic breast cancer | Li, Huiping; Song, Guohong; Zhou, Qiaoxia; Ran, Ran; Jiang, Hanfang; Zhang, Ruyan; Liu, Yaxin; Zhang, Jiayang; Meng, Luping; Ma, Liandong; Sun, Ye; Wang, Meiyu; Zhou, Qingqing; Yan, Honghua; Zhou, Qianxiang; Dong, Xunwei; Tong, Youzhi |
| 2020 | Advances in the Detection Technologies and Clinical Applications of Circulating Tumor DNA in Metastatic Breast Cancer | Liao, Hao; Li, Huiping |
| Feb-2020 | Apatinib in the treatment of HER-2 negative advanced breast cancer with chest wall metastasis multicenter phase II clinical study | Li, Huiping; Geng, Cuizhi; Song, Guohong; Jiang, Hanfang; Tong, Zhongshen; Yang, Junlan; Ran, Ran; Zhang, Ruyan; Liu, Yaxin; Gui, Xinyu; Wei, Maorong; Xue, Lu |
| 2018 | Bilateral breast cancer in China: A 10-year single-center retrospective study | Li, Huiping; Jiang, Hanfang; Zhang, Ruyan; Shao, Bin; Yan, Ying; Ran, Ran; Di, Lijun |
| 2018 | Bilateral breast cancer in China: A 10-year single-center retrospective study | Li, Huiping; Jiang, Hanfang; Zhang, Ruyan; Shao, Bin; Yan, Ying; Ran, Ran; Di, Lijun |
| 2018 | Biomarker analysis by next generation circulating tumor DNA (ctDNA) sequencing in patients with advanced breast cancer | Li, Huiping; Wang, Jing; Rugo, Hope S.; Zhang, Yan; Yang, Ling; Liu, Xiaoran; Shao, Bin; Xu, Yaping; Yang, Liang; Zhang, Ruyan; Ran, Ran; Chang, Lianpeng |
| 2018 | Biomarker analysis by next generation circulating tumor DNA (ctDNA) sequencing in patients with advanced breast cancer | Li, Huiping; Wang, Jing; Rugo, Hope S.; Zhang, Yan; Yang, Ling; Liu, Xiaoran; Shao, Bin; Xu, Yaping; Yang, Liang; Zhang, Ruyan; Ran, Ran; Chang, Lianpeng |
| 2018 | Biomarker analysis from a phase 1 study of palbociclib (PAL) plus letrozole (L) as first-line treatment for ER+/HER2-advanced breast cancer (ABC) in Chinese women | Xu, Binghe; Zhang, Qingyuan; Li, Huiping; Sun, Wan; Li, Wei; Wang, Shusen; Liao, Ning; Shen, Peng; Shao, Bin; Zhao, Wenhui; Liu, Yuan; Li, Vincent; Linn, Carlos; Yan, Ping; Plotka, Anna; Jiang, John; Wang, Diane D. |
| 1-Jun-2024 | Bireociclib plus fulvestrant for advanced HR<SUP>+</SUP>/HER2<SUP>-</SUP> breast cancer progressing after endocrine therapy: Interim analysis of a phase 3 trial (BRIGHT-2) | Wang, Jiayu; Zhang, Qingyuan; Li, Huiping; Tong, Zhongsheng; Ouyang, Quchang; Li, Huihui; Teng, Yuee; Wang, Biyun; Sun, Tao; Wang, Jingfen; Li, Wei; Niu, Zhaofeng; Li, Hongsheng; Gong, Chang; Wang, Li; Liu, Fei; Wang, Shuya; Meng, Yaping; Duan, Xianghui; Xu, Binghe |
| 2014 | Capecitabine maintenance therapy for XT chemotherapy-sensitive patients with metastatic triple-negative breast cancer | Liang, Xu; Di, Lijun; Song, Guohong; Yan, Ying; Wang, Chaoying; Jiang, Hanfang; Li, Huiping |
| Apr-2024 | CDK7 in breast cancer: mechanisms of action and therapeutic potential | Gong, Ying; Li, Huiping |
| 20-May-2020 | Cell-free DNA comparative analysis of hormone receptor-positive, first-line metastatic breast cancer genomic landscape in the United States and China. | Li, Huiping; Davis, Andrew A.; Liu, Xiao-ran; Xie, Feng; Gui, Xin-Yu; Chen, Yi-Fei; Zhang, Qiang; Gerratana, Lorenzo; Zhang, Youbin; Shah, Ami N.; Behdad, Amir; Wehbe, Firas; Huang, Yong; Yu, Jian-Jun; Du, Peter; Jia, Shi-Dong; Cristofanilli, Massimo |
| Sep-2021 | Cell-free DNA comparative analysis of the genomic landscape of first-line hormone receptor-positive metastatic breast cancer from the US and China | Liu, Xiaoran; Davis, Andrew A.; Xie, Feng; Gui, Xinyu; Chen, Yifei; Zhang, Qiang; Gerratana, Lorenzo; Zhang, Youbin; Shah, Ami N.; Behdad, Amir; Wehbe, Firas; Huang, Yong; Yu, Jianjun; Du, Pan; Jia, Shidong; Li, Huiping; Cristofanilli, Massimo |
| 2018 | Clinical outcomes with first-line chemotherapy versus endocrine therapy for adjuvant endocrine therapy-resistant metastatic breast cancer | Shao, Bin; Yang, Yanlian; Qu, Jinrong; Li, Huiping; Song, Guohong; Di, Lijun; Jiang, Hanfang; Yan, Ying; Wang, Huan; Liu, Xiaoran; Wang, Jing; Kong, Weiyao |
| 2018 | Combination versus sequential paclitaxel plus gemcitabine as first-line chemotherapy for women with metastatic breast cancer: a prospective randomized phase II study | Shao, Bin; Song, Guohong; Li, Huiping; Di, Lijun; Jiang, Hanfang; Liang, Xu; Yan, Ying; Zhang, Ruyan; Ran, Ran; Wang, Jing; Liu, Xiaoran; You, Miaoning |
| Feb-2023 | Consumption of ultraprocessed food and development of chronic kidney disease: the Tianjin Chronic Low-Grade Systemic Inflammation and Health and UK Biobank Cohort Studies | Gu, Yeqing; Li, Huiping; Ma, Hao; Zhang, Shunming; Meng, Ge; Zhang, Qing; Liu, Li; Wu, Hongmei; Zhang, Tingjing; Wang, Xuena; Zhang, Juanjuan; Sun, Shaomei; Wang, Xing; Zhou, Ming; Jia, Qiyu; Song, Kun; Liu, Qiang; Huang, Tao; Borne, Yan; Wang, Yaogang; Qi, Lu; Niu, Kaijun |
| 2018 | Deglycosylation of PD-L1 by 2-deoxyglucose reverses PARP inhibitor-induced immunosuppression in triple-negative breast cancer | Shao, Bin; Li, Chia-Wei; Lim, Seung-Oe; Sun, Linlin; Lai, Yun-Ju; Hou, Junwei; Liu, Chunxiao; Chang, Chiung-Wen; Qiu, Yufan; Hsu, Jung-Mao; Chan, Li-Chuan; Zha, Zhengyu; Li, Huiping; Hung, Mien-Chie |
| 2014 | Differential Impact of Tumor-infiltrating Immune Cells on Basal and Luminal Cells: Implications for Tumor Invasion and Metastasis | Song, Guohong; Hsiao, Hsuan; Wang, Jinlian L.; Mannion, Ciaran; Stojadinovic, Alexander; Avital, Itzhak; Fu, Sidney W.; Mason, Jeffrey; Chen, Wen; Jewett, Anahid; Li, Huiping; Man, Yan-Gao |
| 6-May-2024 | Effectiveness of gonadotropin-releasing hormone agonists for ovarian function suppression in premenopausal patients with hormone receptor-positive breast cancer: a retrospective single-center real-world study | Chen, Yifei; Zhang, Ruyan; Yan, Ying; Li, Huiping; Song, Guohong |
